Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (191-200 of 305) with videos related to

Pageof 31
Sort By:
Journal of the American College of Cardiology|May 7, 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER TrialPascal Vranckx, Harvey D White, Zhen Huang, et al.
Revista Espanola De Cardiologia (English Ed.)|December 5, 2017
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationBorja Ibánez, Stefan James, Stefan Agewall, et al.
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
Nature Reviews. Cardiology|July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke preventionDavide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Journal of the American College of Cardiology|February 28, 2015
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidatesMarco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
The Canadian Journal of Cardiology|February 3, 2024
Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding RiskYukio Ozaki, Sung-Jin Hong, Dik Heg, et al.
Circulation|June 13, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Circulation|January 6, 2026
Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary SyndromeSergio Leonardi, Antonio Landi, Andrea Zito, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
JAMA Cardiology|September 27, 2019
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS TrialMariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma, et al.
Pageof 31

Showing results (191-200 of 305) with videos related to

Sort By:
Pageof 31
Journal of the American College of Cardiology|May 7, 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER TrialPascal Vranckx, Harvey D White, Zhen Huang, et al.
Revista Espanola De Cardiologia (English Ed.)|December 5, 2017
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationBorja Ibánez, Stefan James, Stefan Agewall, et al.
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
Nature Reviews. Cardiology|July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke preventionDavide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Journal of the American College of Cardiology|February 28, 2015
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidatesMarco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
The Canadian Journal of Cardiology|February 3, 2024
Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding RiskYukio Ozaki, Sung-Jin Hong, Dik Heg, et al.
Circulation|June 13, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Circulation|January 6, 2026
Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary SyndromeSergio Leonardi, Antonio Landi, Andrea Zito, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
JAMA Cardiology|September 27, 2019
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS TrialMariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma, et al.
Pageof 31